Thrombolysis in Patients With Mild Stroke
Author(s) -
Stefan Greisenegger,
Leonhard Seyfang,
Stefan Kiechl,
Wilfried Lang,
Julia Ferrari
Publication year - 2014
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.113.003827
Subject(s) - medicine , stroke (engine) , thrombolysis , modified rankin scale , diabetes mellitus , odds ratio , confidence interval , tissue plasminogen activator , surgery , ischemic stroke , ischemia , myocardial infarction , mechanical engineering , engineering , endocrinology
Apart from missing the approved time window of 4.5 hours, one frequent cause for withholding recombinant tissue plasminogen activator (rt-PA) treatment in patients with ischemic stroke is presentation with mild deficit on admission. We analyzed in a large cohort of patients whether rt-PA treatment is beneficial for this group of patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom